EUVIMEDOdkrijte EUVIMED
Open access

Influenza During the 2010–2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions

Ryan E Malosh, Ian McGovern, Arnold S Monto

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac653 ↗

At a glance

Journal article in Clinical Infectious Diseases, 2023. Written by Ryan E Malosh and 2 co-authors. Institution: Division of Immunizations, Michigan Department of Health and Human Services, Lansing, Michigan, USA. Major MEDLINE topics: Influenza, Human, COVID-19, Influenza Vaccines. Cited 33 times so far (Crossref); 40 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, (NIAID).

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

The 10 years between the last influenza pandemic and start of the severe acute respiratory syndrome coronavirus 2 pandemic have been marked by great advances in our ability to follow influenza occurrence and determine vaccine effectiveness (VE), largely based on widespread use of the polymerase chain reaction assay. We examine the results, focusing mainly on data from the United States and inactivated vaccines. Surveillance has expanded, resulting in increased ability to characterize circulating viruses and their impact. The surveillance has often confirmed previous observations on timing of outbreaks and age groups affected, which can now be examined in greater detail. Selection of strains for vaccines is now based on enhanced viral characterization using immunologic, virologic, and computational techniques not previously available. Vaccine coverage has been largely stable, but VE has remained modest and, in some years, very low. We discuss ways to improve VE based on existing technology while we work toward supraseasonal vaccines.

Subjects

MeSH terms (MEDLINE)

Influenza, HumanCOVID-19Influenza VaccinesHumansUnited StatesInfantSeasonsInfluenza A Virus, H3N2 SubtypeDisease OutbreaksVaccination

Author keywords

influenzainfluenza vaccinespublic health surveillancesentinel surveillancevaccine effectiveness

Substances

Influenza Vaccines

Authors and institutions

  • Division of Immunizations, Michigan Department of Health and Human Services, Lansing, Michigan, USA.
  • Center for Outcomes Research and Epidemiology, Seqirus USA Inc, Cambridge, Massachusetts, USA.
  • School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.

Funding

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • (NIAID)

Cite

APA

Malosh, R. E., McGovern, I., & Monto, A. S. (2023). Influenza During the 2010–2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac653

Vancouver

Malosh RE, McGovern I, Monto AS. Influenza During the 2010–2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac653

BibTeX
@article{Malosh2023,
  author = {Malosh, Ryan E and McGovern, Ian and Monto, Arnold S},
  title = {Influenza During the 2010–2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac653}
}
Start for free →